From Prototype to
Clinical Standard.

We are executing a phased rollout strategy, prioritizing rigorous validation on open datasets before moving to proprietary clinical pilots and global scaling.

Current Phase

Phase 1: Validation

2026

Focus on the Clinical Auditing Framework. We are implementing the "Glass Box" layer using PyTorch and Captum to ensure all model outputs are physiologically verifiable.

  • • Implement IntegratedGradients (Captum)
  • • Validate "Reverse Neuro-Attribution" on open data
  • • Recruit Regulatory Affairs Specialist
🛠️

Milestone

Technical Proof-of-Concept

Achieve >95% accuracy in distinguishing between Neural Oscillations and Muscle Artifacts using the Audit Layer.

🏥

Milestone

First Clinical Pilot

Deploy "NeuroSonic Beta" in Comenius University sleep labs to collect sleep-specific paired data (Spindles/K-Complexes).

Expansion

Phase 2: The Stress Test

2027

Moving from code to Clinical Stress Testing. We will deploy the Audit Layer in partner sleep labs to flag "hallucinations" in real-time during sleep studies.

  • • Real-time Hemodynamic Lag monitoring
  • • Cross-validation with invasive EEG (iEEG) data
  • • Publish "Transparency Report" for EU AI Act compliance
Commercialization

Phase 3: The Scale

Spring 2028

Launch of the NeuroSonic Certified Platform. We will offer the first "Audited AI" pipeline that fully satisfies the High-Risk requirements of the EU AI Act.

  • • Full CE Mark (MDR) Application
  • • B2B Launch for Hospital IT Departments
  • • Integration with Electronic Health Records (Epic/Cerner)
🚀

Milestone

Market Entry

Transition from "Project" to "Venture." Full-time focus on scaling the business infrastructure and client base.